HOME >> BIOLOGY >> NEWS
Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice

ATLANTA-- Emory University scientists have for the first time used a new class of luminescent "quantum dot" nanoparticles in living animals to simultaneously target and image cancerous tumors. The quantum dots were encapsulated in a highly protective polymer coating and attached to a monoclonal antibody that guided them to prostate tumor sites in living mice, where they were visible using a simple mercury lamp. The scientists believe the ability to both target and image cells in vivo represents a significant step in the quest to eventually use nanotechnology to target, image, and treat cancer, cardiovascular plaques, and neurodegenerative disease in humans. The findings were published on-line July 18 in the journal Nature Biotechnology and will appear in the journal's August 1 print edition.

The research team was led by Shuming Nie, PhD, a nanotechnology expert and a professor in the Coulter Department of Biomedical Engineering at Emory and the Georgia Institute of Technology and in Emory's Winship Cancer Institute, and by Lelund Chung, PhD, professor of urology in Emory University School of Medicine and the Winship Cancer Institute. Quantum dots are nanometer-sized luminescent semiconductor crystals that have unique chemical and physical properties due to their size and their highly compact structure. Quantum dots can be chemically linked (conjugated) to molecules such as antibodies, peptides, proteins or DNA and engineered to detect other molecules, such as those present on the surface of cancer cells.

The researchers injected human prostate cancer cells under the skin of mice to promote growth of solid prostate tumors. They then encapsulated quantum dots, made from cadmium selenide, within a highly protective coating called an ABC triblock copolymer, and over-coated the particle-polymer composite with poly (ethylene glycol). They injected the quantum dots into the circulatory system of the mice first to test "passive" targeting of the
'"/>

Contact: Holly Korschun
404-727-3990
Emory University Health Sciences Center
27-Jul-2004


Page: 1 2 3

Related biology news :

1. Newly identified master gene key in babys first breath
2. Newly discovered protein may be key to muscular dystrophy
3. Newly grown kidneys can sustain life in rats
4. Newly discovered gene controls levels of bad cholesterol in mice
5. Newly identified gene linked to brain development
6. Newly cloned gene key to global adaptation of wheat
7. Newly identified genes may help predict outcome in childhood leukemia
8. Newly identified gene may halt fuzzy, moldy fruit
9. Newly found gene resistant to economically crippling wheat disease
10. Newly invented Endometrial Function Test (EFT®) solves the puzzle of unexplained infertility
11. Newly mapped enzyme could yield new treatments for female sexual dysfunction

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/26/2019)... ... October 23, 2019 , ... ... Cell Imaging System including Digital Confocal 2D on-the-fly deconvolution, Live Preview mode, ... scientists to decrease exposure time and improve the statistical significance of their ...
(Date:10/26/2019)... ... ... World Cord Blood Day (WCBD) takes place on November 15, 2019, and will ... and future uses of cord blood stem cells, and the potential cord blood has ... over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle cell anemia. It is ...
(Date:10/26/2019)... ... October 25, 2019 , ... Leak Detection Associates ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to ... the SIMS Model 1915+ . The SIMS 1915+ unit is engineered incorporating ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November ... , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology ...
(Date:10/22/2019)... ... ... Catalent, a global leader in clinical supply services, today announced that Ann McMahon, ... panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal ... 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at 8:30 a.m., comes ...
(Date:10/17/2019)... (PRWEB) , ... October 16, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling information, has published a new white paper ... year period and provides guidance as to how patients and medical providers can ...
(Date:10/10/2019)... ... 2019 , ... R3 Stem Cell announces it has added an exosome presentation ... Las Vegas with spots still open. , The speaker, Dr. Ian White PhD, is ... including Cornell, Harvard and Dartmouth. He currently serves as the Chief Scientific Officer at ...
Breaking Biology Technology:
Cached News: